Our Drug Development Model

To advance our promising drug candidates as quickly as possible toward regulatory approval, Insignis works with carefully selected strategic partners to leverage their complementary resources and drug development expertise and industry leading CDMOs for API and drug product development and manufacture. This drug development model enables us to achieve record speed in reaching key drug development milestones (INDs and NDAs).